SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 137 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $136,000 | -4.2% | 23,413 | 0.0% | 0.06% | -5.9% |
Q1 2016 | $142,000 | -33.6% | 23,413 | 0.0% | 0.07% | -33.3% |
Q4 2015 | $214,000 | +62.1% | 23,413 | 0.0% | 0.10% | +52.2% |
Q3 2015 | $132,000 | -49.2% | 23,413 | 0.0% | 0.07% | -43.2% |
Q2 2015 | $260,000 | -29.2% | 23,413 | 0.0% | 0.12% | -29.8% |
Q1 2015 | $367,000 | – | 23,413 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
Leisure Capital Management | 43,008 | $131,000 | 0.12% |
Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |